Hypoxia-induced alterations in the lung ubiquitin proteasome system during pulmonary hypertension pathogenesis
暂无分享,去创建一个
Jing Ma | C. Hart | Jingru Zhao | Jingru Zhao | R. Sutliff | C. Michael Hart | Brandy E. Wade | Roy L. Sutliff | Jing Ma
[1] M. Schleicher,et al. Effects of single amino acid substitutions in the actin-binding site on the biological activity of bovine profilin I. , 1998, Journal of cell science.
[2] C. Hart,et al. Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. , 2010, American journal of respiratory cell and molecular biology.
[3] Yinxia Wu,et al. Inhibition of ubiquitin proteasome function prevents monocrotaline‐induced pulmonary arterial remodeling , 2017, Life sciences.
[4] R. Johns,et al. S100A11 Mediates Hypoxia-induced Mitogenic Factor (HIMF)-induced Smooth Muscle Cell Migration, Vesicular Exocytosis, and Nuclear Activation* , 2010, Molecular & Cellular Proteomics.
[5] P. Chavrier,et al. Proteasome-mediated degradation of Rac1-GTP during epithelial cell scattering. , 2006, Molecular biology of the cell.
[6] George A Mensah,et al. Pulmonary hypertension surveillance--United States, 1980-2002. , 2005, Morbidity and mortality weekly report. Surveillance summaries.
[7] G. Semenza,et al. SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1α ubiquitination and degradation , 2008, Oncogene.
[8] Hongyu Ruan,et al. Proteasome-independent polyubiquitin linkage regulates synapse scaffolding, efficacy, and plasticity , 2017, Proceedings of the National Academy of Sciences.
[9] P. Cash,et al. Proteomic changes in the brain of the western painted turtle (Chrysemys picta bellii) during exposure to anoxia , 2015, Proteomics.
[10] Jianmin Wu,et al. Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker. , 2014, The international journal of biochemistry & cell biology.
[11] M. Pagano,et al. The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer. , 2014, Biochimica et biophysica acta.
[12] K. Nakanishi,et al. Proteomic analysis of the lung in rats with hypobaric hypoxia-induced pulmonary hypertension. , 2013, Histology and Histopathology.
[13] L. Rubin,et al. Prostacyclin and PGE1 treatment of pulmonary hypertension. , 1987, The American review of respiratory disease.
[14] P. D. Moens,et al. Structure and functions of profilins , 2009, Biophysical Reviews.
[15] Y. Oh,et al. Bortezomib alleviates experimental pulmonary arterial hypertension. , 2012, American journal of respiratory cell and molecular biology.
[16] Haiyang Tang,et al. Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCs. , 2016, American journal of physiology. Cell physiology.
[17] Zhichao Zhou,et al. FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression. , 2013, Molecular medicine reports.
[18] P. Cohen,et al. Two different classes of E2 ubiquitin-conjugating enzymes are required for the mono-ubiquitination of proteins and elongation by polyubiquitin chains with a specific topology. , 2008, The Biochemical journal.
[19] Z. Ronai,et al. Dysregulation of ubiquitin ligases in cancer. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[20] X. Qiu,et al. Ubiquitin at the crossroad of cell death and survival , 2013, Chinese journal of cancer.
[21] G. Qian,et al. JAK—STAT signaling pathway in pulmonary arterial smooth muscle cells is activated by hypoxia , 2005, Cell biology international.
[22] Susan O Griffin,et al. Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis--United States, 1988-1994 and 1999-2002. , 2005, Morbidity and mortality weekly report. Surveillance summaries.
[23] Fátima Sánchez-Cabo,et al. GOplot: an R package for visually combining expression data with functional analysis , 2015, Bioinform..
[24] N. Sharma,et al. The proteome of Hypobaric Induced Hypoxic Lung: Insights from Temporal Proteomic Profiling for Biomarker Discovery , 2015, Scientific Reports.
[25] Dysregulation of PTEN in Cardiopulmonary Vascular Remodeling Induced by Pulmonary Hypertension , 2013, Cell Biochemistry and Biophysics.
[26] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[27] M. Rapé,et al. Mechanism of Ubiquitin-Chain Formation by the Human Anaphase-Promoting Complex , 2008, Cell.
[28] T. Sixma,et al. Target Specificity of the E3 Ligase LUBAC for Ubiquitin and NEMO Relies on Different Minimal Requirements , 2013, The Journal of Biological Chemistry.
[29] Hui Zhang,et al. Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker , 2012, Tumor Biology.
[30] K. Schilling,et al. NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS , 2005, Journal of Cell Science.
[31] M. Gotta,et al. Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin , 2007, Nature.
[32] D. Latchman,et al. SAG attenuates apoptotic cell death caused by simulated ischaemia/reoxygenation in rat cardiomyocytes. , 2003, Journal of molecular and cellular cardiology.
[33] P. Hordijk,et al. The role of ubiquitylation and degradation in RhoGTPase signalling , 2010, Journal of Cell Science.
[34] Mary G. George,et al. Pulmonary Hypertension Surveillance , 2014, Chest.
[35] Zhaohua Zhang,et al. Proteasome inhibitor PS-341 attenuates flow-induced pulmonary arterial hypertension , 2014, Clinical and Experimental Medicine.
[36] E. Michelakis,et al. The Metabolic Theory of Pulmonary Arterial Hypertension , 2014, Circulation research.
[37] P. Dorfmuller,et al. Pathology and Pathobiology of Pulmonary Hypertension , 2013, Seminars in Respiratory and Critical Care Medicine.
[38] G. Melino,et al. Transglutaminase-dependent RhoA Activation and Depletion by Serotonin in Vascular Smooth Muscle Cells* , 2007, Journal of Biological Chemistry.
[39] Zong-fang Li,et al. Inhibition of ubiquitin proteasome function suppresses proliferation of pulmonary artery smooth muscle cells , 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.
[40] N. Opitz,et al. NOSTRIN: A protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[41] W. Seeger,et al. Fhl-1, a New Key Protein in Pulmonary Hypertension , 2008, Circulation.
[42] A. Wells,et al. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness , 2007, British Journal of Cancer.
[43] J. Pines,et al. The biochemistry of mitosis. , 2015, Cold Spring Harbor perspectives in biology.
[44] J. Segal,et al. Pulmonary Hypertension Therapy and a Systematic Review of Efficacy and Safety of PDE-5 Inhibitors , 2017, Pediatrics.
[45] T. Svitkina,et al. Actin machinery: pushing the envelope. , 2000, Current opinion in cell biology.
[46] Z. Miao,et al. c-Jun protects hypoxia-inducible factor-1alpha from degradation via its oxygen-dependent degradation domain in a nontranscriptional manner. , 2009, Cancer research.
[47] G. Semenza,et al. SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1 alpha ubiquitination and degradation. , 2008, Oncogene.
[48] S. Eddahibi,et al. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. , 1995, The American journal of physiology.
[49] Ivan Dikic,et al. Ubiquitination in disease pathogenesis and treatment , 2014, Nature Medicine.
[50] Anindya Dutta,et al. Genomic instability in cancer. , 2013, Cold Spring Harbor perspectives in biology.
[51] P. Graceffa,et al. Actin polymerization in differentiated vascular smooth muscle cells requires vasodilator-stimulated phosphoprotein. , 2010, American journal of physiology. Cell physiology.
[52] D. Duong,et al. GPRC5A suppresses protein synthesis at the endoplasmic reticulum to prevent radiation-induced lung tumorigenesis , 2016, Nature Communications.
[53] T. Flatmark,et al. Ubiquitinated annexin A2 is enriched in the cytoskeleton fraction , 2005, FEBS letters.
[54] M. Humbert,et al. Pathogenesis of pulmonary arterial hypertension: lessons from cancer , 2013, European Respiratory Review.
[55] S. C. Chafe,et al. Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis , 2012, Nature.
[56] R. Mathew,et al. Smurf1 ubiquitin ligase causes downregulation of BMP receptors and is induced in monocrotaline and hypoxia models of pulmonary arterial hypertension , 2010, Experimental biology and medicine.
[57] K. Irani,et al. Redox Regulation of Human Rac1 Stability by the Proteasome in Human Aortic Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[58] Yuichiro J Suzuki,et al. Carfilzomib reverses pulmonary arterial hypertension. , 2016, Cardiovascular research.
[59] Zhijian J. Chen,et al. Both K63 and K48 ubiquitin linkages signal lysosomal degradation of the LDL receptor , 2013, Journal of Lipid Research.
[60] Jeroen A. A. Demmers,et al. An immunoaffinity purification method for the proteomic analysis of ubiquitinated protein complexes. , 2013, Analytical biochemistry.
[61] Jeffrey R. Johnson,et al. Non-degradative Ubiquitination of Protein Kinases , 2016, PLoS Comput. Biol..
[62] R. Tikkanen,et al. Translocation of endothelial nitric-oxide synthase involves a ternary complex with caveolin-1 and NOSTRIN. , 2006, Molecular biology of the cell.
[63] U. Christians,et al. Comparison of lung proteome profiles in two rodent models of pulmonary arterial hypertension , 2007, Proteomics.
[64] Yih-Jer Wu,et al. Proliferation unleashed: the role of Skp2 in vascular smooth muscle cell proliferation. , 2011, Frontiers in bioscience.
[65] I. Aukrust,et al. Post‐translational modifications of Annexin A2 are linked to its association with perinuclear nonpolysomal mRNP complexes , 2017, FEBS open bio.
[66] J. Catravas,et al. Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension. , 2009, Physiological genomics.
[67] J. Benada,et al. Targeting the Checkpoint to Kill Cancer Cells , 2015, Biomolecules.
[68] Edward L. Huttlin,et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. , 2011, Molecular cell.
[69] Jung-Hwan Yoon,et al. Differential sensitivity of hepatocellular carcinoma cells to suppression of hepatocystin transcription under hypoxic conditions , 2016, Journal of Bioenergetics and Biomembranes.
[70] Zhijian J. Chen,et al. Nonproteolytic functions of ubiquitin in cell signaling. , 2009, Molecular cell.
[71] P. Howley,et al. In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.
[72] C. Prigent,et al. Annexin A2 is required for the early steps of cytokinesis , 2015, EMBO reports.
[73] R. Tuder,et al. Pathology of pulmonary hypertension. , 2013, Clinics in chest medicine.
[74] D. Liao,et al. Proteomic Analysis Reveals that Proteasome Subunit Beta 6 Is Involved in Hypoxia-Induced Pulmonary Vascular Remodeling in Rats , 2013, PloS one.
[75] CHFR: a key checkpoint component implicated in a wide range of cancers , 2012, Cellular and Molecular Life Sciences.
[76] L. Carrier,et al. The ubiquitin–proteasome system in cardiomyopathies , 2011, Current opinion in cardiology.
[77] Yue Zhang,et al. Regulation of Cell Polarity and Protrusion Formation by Targeting RhoA for Degradation , 2003, Science.
[78] D. Barford,et al. Insights into the anaphase-promoting complex: a molecular machine that regulates mitosis. , 2014, Current opinion in structural biology.
[79] Yi Sun,et al. SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation. , 2007, Cancer research.
[80] J. Hoppin,et al. Muscle RING Finger-1 Promotes a Maladaptive Phenotype in Chronic Hypoxia-Induced Right Ventricular Remodeling , 2014, PloS one.
[81] R. Karlsson,et al. Evidence for two interaction regions for phosphatidylinositol(4,5)‐bisphosphate on mammalian profilin I , 2002, FEBS letters.
[82] D. Komander. The emerging complexity of protein ubiquitination. , 2009, Biochemical Society transactions.
[83] S. Archer,et al. Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension , 2018, Hypertension.
[84] R. Mallampalli,et al. Regulation of inflammasomes by ubiquitination , 2016, Cellular & Molecular Immunology.
[85] B. Kang,et al. Hypoxia inhibits expression and function of mitochondrial thioredoxin 2 to promote pulmonary hypertension. , 2017, American journal of physiology. Lung cellular and molecular physiology.
[86] Daniela Hoeller,et al. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis , 2006, Nature Reviews Cancer.
[87] Zhiwei Wang,et al. Targeting the ubiquitin pathway for cancer treatment. , 2015, Biochimica et biophysica acta.
[88] Haiqing Gao,et al. Profilin-1 Promotes the Development of Hypertension-induced Artery Remodeling , 2014, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[89] Shreya Paliwal,et al. The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks , 2011, Nature Cell Biology.